Aster DM Healthcare Limited
NSE: ASTERDM BSE: ASTERDM
Prev Close
596.05
Open Price
599
Volume
350,154
Today Low / High
586 / 599
52 WK Low / High
315.5 / 609.5
Range
560 - 619
Prev Close
596.05
Open Price
596.7
Volume
10,009
Today Low / High
585.6 / 597.65
52 WK Low / High
315.5 / 609
Range
560 - 619
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 589.7 (target range: 560 - 619), reflecting a change of -6.35 (-1.06535%). On the BSE, it is listed at 589.6 (target range: 560 - 619), showing a change of -6.45 (-1.08212%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
Aster DM Healthcare Limited Graph
Aster DM Healthcare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Aster DM Healthcare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 589.70, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 589.60 | 595.50 | 535.95 - 655.05 |
| 601.39 | 481.11 - 721.67 | ||
| 607.29 | 425.10 - 789.47 | ||
| Bearish Scenario | 589.60 | 583.70 | 525.33 - 642.07 |
| 577.81 | 462.25 - 693.37 | ||
| 571.91 | 400.34 - 743.49 |
Overview of Aster DM Healthcare Limited
ISIN
INE914M01019
Industry
Medical - Care Facilities
Vol.Avg
979,009
Market Cap
305,535,953,700
Last Dividend
6
Official Website
IPO Date
2018-02-26
DCF Diff
399.00
DCF
189
Financial Ratios Every Investor Needs
Stock Dividend of ASTERDM
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-02-10 | February 10, 25 | 4 | 4 | 2025-02-10 | 2025-03-02 | |
| 2024-08-22 | August 22, 24 | 2 | 2 | 2024-08-22 | 2024-09-28 | |
| 2024-04-23 | April 23, 24 | 118 | 118 | 2024-04-23 | 2024-05-12 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 4,138.46 Cr | 1,727.93 Cr | 2,410.53 Cr | 0.5825 | 0.00 Cr | 921.17 Cr | 515.69 Cr | 5,377.83 Cr | 6.16 | 770.37 Cr | 1.2995 |
| 2024-03-31 | 3,698.90 Cr | 1,723.05 Cr | 1,975.85 Cr | 0.5342 | 0.00 Cr | 882.75 Cr | 940.44 Cr | 129.28 Cr | 2.60 | 611.57 Cr | 0.0350 |
| 2023-03-31 | 11,932.88 Cr | 3,531.82 Cr | 8,401.06 Cr | 0.7040 | 14.48 Cr | 1,038.34 Cr | 786.18 Cr | 424.91 Cr | 8.54 | 1,061.05 Cr | 0.0356 |
| 2022-03-31 | 10,253.28 Cr | 2,908.96 Cr | 7,344.32 Cr | 0.7163 | 4.58 Cr | 946.28 Cr | 843.93 Cr | 525.99 Cr | 10.58 | 1,583.74 Cr | 0.0513 |
| 2021-03-31 | 8,608.43 Cr | 2,560.64 Cr | 6,047.79 Cr | 0.7025 | 0.00 Cr | 758.26 Cr | 447.51 Cr | 147.74 Cr | 2.97 | 1,152.69 Cr | 0.0172 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1,380.00 Cr | 6,606.38 Cr | 2,954.93 Cr | 3,428.0700 Cr | 2,017.77 Cr | 637.77 Cr | 92.35 Cr | 3,918.57 Cr | 0.00 Cr | 0.00 Cr | 243.69 Cr | 879.2100 Cr |
| 2024-03-31 | 82.23 Cr | 17,991.31 Cr | 12,961.20 Cr | 4,559.7900 Cr | 1,383.75 Cr | 1,301.52 Cr | 137.57 Cr | 3,049.91 Cr | 27.02 Cr | 49.10 Cr | -14.60 Cr | 11,288.2600 Cr |
| 2023-03-31 | 378.53 Cr | 14,881.20 Cr | 10,020.74 Cr | 4,448.0700 Cr | 5,700.30 Cr | 5,321.77 Cr | 1,305.62 Cr | 7,803.62 Cr | 238.21 Cr | 623.61 Cr | 91.12 Cr | 4,655.2800 Cr |
| 2022-03-31 | 343.37 Cr | 12,546.24 Cr | 8,063.62 Cr | 3,953.4100 Cr | 4,907.13 Cr | 4,563.76 Cr | 1,025.68 Cr | 6,640.37 Cr | 452.50 Cr | 26.19 Cr | 58.23 Cr | 3,558.5800 Cr |
| 2021-03-31 | 258.09 Cr | 11,643.46 Cr | 7,809.34 Cr | 3,372.4600 Cr | 4,803.65 Cr | 4,545.56 Cr | 848.99 Cr | 6,380.57 Cr | 383.39 Cr | 30.24 Cr | 58.16 Cr | 3,195.6200 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 425.0500 Cr | 6,014.8700 Cr | -6,357.8100 Cr | 79.0100 Cr | -532.8700 Cr | 164.5900 Cr | -356.7300 Cr | 5,377.8300 Cr | -59.5600 Cr | -6,173.2400 Cr | 18.1700 Cr |
| 2024-03-31 | 157.8100 Cr | -884.6500 Cr | 1,052.8300 Cr | -647.7700 Cr | 332.3900 Cr | 697.4600 Cr | -796.9100 Cr | 129.2800 Cr | 1,810.7100 Cr | 0.0000 Cr | -303.0300 Cr |
| 2023-03-31 | 1,833.9800 Cr | -971.8800 Cr | -817.3900 Cr | 985.7500 Cr | 65.7400 Cr | 365.0700 Cr | -848.2300 Cr | 535.0800 Cr | -689.6400 Cr | 0.0000 Cr | -192.9800 Cr |
| 2022-03-31 | 1,313.4600 Cr | -570.4800 Cr | -685.4200 Cr | 765.4900 Cr | 64.7800 Cr | 299.3300 Cr | -547.9700 Cr | 636.8500 Cr | -179.6000 Cr | 0.0000 Cr | -144.6000 Cr |
| 2021-03-31 | 1,569.1200 Cr | -330.3000 Cr | -1,116.1300 Cr | 1,145.4700 Cr | 119.9000 Cr | 234.5500 Cr | -423.6500 Cr | 205.0500 Cr | -618.2600 Cr | 0.0000 Cr | 94.5700 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1,000.33 Cr | 415.18 Cr | 291.23 Cr | 0.2911 | 355.17 Cr | 79.02 Cr | 1.59 | 191.78 Cr | 0.0790 |
| 2024-12-31 | 1,049.81 Cr | 247.01 Cr | 802.80 Cr | 0.7647 | 126.97 Cr | 56.79 Cr | 1.14 | 194.86 Cr | 0.0541 |
| 2024-09-30 | 1,086.44 Cr | 737.96 Cr | 348.48 Cr | 0.3208 | 157.47 Cr | 96.84 Cr | 1.94 | 252.29 Cr | 0.0891 |
| 2024-06-30 | 1,001.87 Cr | 710.97 Cr | 290.90 Cr | 0.2904 | 103.13 Cr | 5,145.18 Cr | 103.45 | 163.54 Cr | 5.1356 |
| 2024-03-31 | 973.59 Cr | 687.35 Cr | 286.24 Cr | 0.2940 | 100.98 Cr | -24.03 Cr | -0.48 | -233.74 Cr | -0.0247 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1,380.00 Cr | 1.42 Cr | 1,381.42 Cr | 257.81 Cr | 92.35 Cr | 1,901.47 Cr | 3,918.57 Cr | 6,606.38 Cr | 2,954.93 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 1,578.16 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -3,601.50 Cr |
| 2024-09-30 | 914.57 Cr | 1.42 Cr | 1,578.16 Cr | 262.33 Cr | 114.35 Cr | 2,097.82 Cr | 3,801.64 Cr | 6,687.60 Cr | 3,086.10 Cr |
| 2024-06-30 | -115.95 Cr | 231.90 Cr | 115.95 Cr | 0.00 Cr | 0.00 Cr | 115.95 Cr | 0.00 Cr | 0.00 Cr | -5,030.11 Cr |
| 2024-03-31 | 112.65 Cr | 3.30 Cr | 115.95 Cr | 261.64 Cr | 110.52 Cr | 14,165.30 Cr | 3,049.95 Cr | 17,991.31 Cr | 12,961.20 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 79.02 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 56.79 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 96.84 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 5,145.18 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | -24.03 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Care Facilities
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Max Healthcare Institute Limited | MAXHEALTH | ₹1,279.70 | ₹1,244,056,515,900.00 | ₹2,067,074.00 |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹7,496.00 | ₹1,077,812,360,000.00 | ₹1,872,418.00 |
| Fortis Healthcare Limited | FORTIS | ₹774.75 | ₹584,903,710,500.00 | ₹1,742,864.00 |
| Narayana Hrudayalaya Limited | NH | ₹2,094.00 | ₹427,931,934,000.00 | ₹766,592.00 |
| Global Health Limited | MEDANTA | ₹1,151.40 | ₹309,251,497,818.00 | ₹194,407.00 |
| Aster DM Healthcare Limited | ASTERDM | ₹589.70 | ₹305,535,953,700.00 | ₹350,154.00 |
| Krishna Institute of Medical Sciences Limited | KIMS | ₹686.25 | ₹274,595,388,750.00 | ₹871,855.00 |
| Rainbow Children's Medicare Limited | RAINBOW | ₹1,572.40 | ₹159,679,852,198.00 | ₹212,510.00 |
| HealthCare Global Enterprises Limited | HCG | ₹538.35 | ₹75,054,065,250.00 | ₹553,730.00 |
| Yatharth Hospital & Trauma Care Services Limited | YATHARTH | ₹548.80 | ₹52,879,270,024.00 | ₹1,091,828.00 |
| Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹486.40 | ₹44,589,747,200.00 | ₹552,298.00 |
| Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
| Artemis Medicare Services Limited | ARTEMISMED | ₹252.90 | ₹35,127,810,000.00 | ₹57,008.00 |
Key Executives
Gender: Not Specified
Year Born: 1953
Gender: male
Year Born: 1972
Gender: male
Year Born: 1961
Gender: male
Year Born:
Gender: male
Year Born:
Gender: Not Specified
Year Born: 1954
Gender: female
Year Born: 1982
Gender: male
Year Born:
Gender: Not Specified
Year Born: 1975
Gender: male
Year Born:
FAQs about Aster DM Healthcare Limited
The CEO is Alisha Moopen.
The current price is ₹589.70.
The range is ₹315.5-609.5.
The market capitalization is ₹30,553.60 crores.
The dividend yield is 1.02%.
The P/E ratio is 5.48.
The company operates in the Healthcare sector.
Overview of Aster DM Healthcare Limited (ISIN: INE914M01019) is a leading Medical - Care Facilities in India. With a market capitalization of ₹30,553.60 crores and an average daily volume of 979,009 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹6.